Enfortumab Vedotin Induced Hyperglycemia and Diabetic Ketoacidosis

被引：0
|
作者：
Patel, J. [1 ]
机构：
[1] Rush Univ, Med Ctr, Pulm & Crit Care Med, Chicago, IL 60612 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5298
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Enfortumab Vedotin in urothelial cancer
    Alt, Marie
    Stecca, Carlos
    Tobin, Swanee
    Jiang, Di Maria
    Sridhar, Srikala S.
    THERAPEUTIC ADVANCES IN UROLOGY, 2020, 12
  • [22] Enfortumab vedotin is safe and effective
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (07) : 400 - 400
  • [23] Diabetic Ketoacidosis and Profound Insulin Resistance From Brentuximab Vedotin
    Thakkar, Keval
    Khurana, Sonali
    Sun, Yujiao
    Hembree, Timothy N.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)
  • [24] Brentuximab vedotin-associated diabetic ketoacidosis: a case report
    Damla Köksalan
    Mehmet Sözen
    Alev Selek
    Emre Gezer
    Zeynep Cantürk
    Berrin Çetinarslan
    International Journal of Diabetes in Developing Countries, 2023, 43 : 120 - 124
  • [25] Brentuximab vedotin-associated diabetic ketoacidosis: a case report
    Koksalan, Damla
    Sozen, Mehmet
    Selek, Alev
    Gezer, Emre
    Canturk, Zeynep
    Cetinarslan, Berrin
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2023, 43 (01) : 120 - 124
  • [26] Enfortumab Vedotin in Advanced Urothelial Carcinoma
    Petrylak, Daniel P.
    Powles, Thomas
    Rosenberg, Jonathan E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (01): : 93 - 94
  • [27] Flexural Exanthema From Enfortumab Vedotin
    Keerty, Dinesh
    Graham, Laura
    Haynes, Elizabeth
    Hembree, Timothy N.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (05)
  • [28] Enfortumab vedotin to treat urothelial carcinoma
    Hanna, K. S.
    DRUGS OF TODAY, 2020, 56 (05) : 329 - 335
  • [29] Enfortumab vedotin-ejfv (Padcev)
    不详
    AMERICAN JOURNAL OF NURSING, 2021, 121 (12) : 16 - 17
  • [30] Characterization of cutaneous adverse events to enfortumab vedotin
    Shahin, A.
    Janeczek, M.
    Butterfield, R.
    Bhullar, P.
    Boudreaux, B.
    Ho, T.
    Mangold, A. R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : B9 - B9
12345